Jane Grogan - GRPH Old Chief Officer
| GRPHDelisted Stock | USD 2.67 0.05 1.84% |
Insider
Jane Grogan is Chief Officer of GRPH Old
| Age | 56 |
| Phone | 650 484 0886 |
| Web | https://graphitebio.com |
GRPH Old Management Efficiency
The company has return on total asset (ROA) of (0.1799) % which means that it has lost $0.1799 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5195) %, meaning that it created substantial loss on money invested by shareholders. GRPH Old's management efficiency ratios could be used to measure how well GRPH Old manages its routine affairs as well as how well it operates its assets and liabilities.GRPH Old currently holds 362 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. GRPH Old has a current ratio of 26.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about GRPH Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| MPH MBA | Sensei Biotherapeutics | N/A | |
| Oleg Nodelman | Nuvation Bio | 44 | |
| Tharaknath Rao | Assembly Biosciences | N/A | |
| David MD | Nuvation Bio | 55 | |
| Julia Wilson | Achilles Therapeutics PLC | N/A | |
| Robert MD | Sensei Biotherapeutics | 58 | |
| Daniel Welch | Nuvation Bio | 63 | |
| MBA BS | CytomX Therapeutics | 46 | |
| W Vernon | Nuvation Bio | 65 | |
| Karl MD | Achilles Therapeutics PLC | 57 | |
| Sergey Yurasov | Nuvation Bio | 51 | |
| DPHIL DPhil | CytomX Therapeutics | 57 | |
| BSc FRCPath | Achilles Therapeutics PLC | 59 | |
| MD FACP | NextCure | 71 | |
| Gary Hattersley | Nuvation Bio | 58 | |
| FMEDSCI MD | Achilles Therapeutics PLC | 49 | |
| Kerry Wentworth | Nuvation Bio | 52 | |
| Stacy Markel | Nuvation Bio | 60 | |
| Iraj Ali | Achilles Therapeutics PLC | 50 | |
| Michele Anderson | Assembly Biosciences | N/A | |
| MBA MBA | Sensei Biotherapeutics | 52 | |
Management Performance
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 |
GRPH Old Leadership Team
Elected by the shareholders, the GRPH Old's board of directors comprises two types of representatives: GRPH Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GRPH. The board's role is to monitor GRPH Old's management team and ensure that shareholders' interests are well served. GRPH Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GRPH Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephanie Yao, Vice Relations | ||
| Maria MD, Academic Board | ||
| Christine PMP, Chief Operations | ||
| Jerry Cacia, Chief Officer | ||
| Philip Gutry, Chief Officer | ||
| Jane Grogan, Chief Officer | ||
| MD FACC, CEO Pres | ||
| Daniel Dever, CoFounder Research | ||
| Alethia Young, Chief Officer | ||
| Kimberlee CPA, CEO and Presidentident | ||
| Matthew MD, Academic Director |
GRPH Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GRPH Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 1.88 M | |||
| Shares Outstanding | 58.24 M | |||
| Shares Owned By Insiders | 9.17 % | |||
| Shares Owned By Institutions | 84.40 % | |||
| Number Of Shares Shorted | 704.04 K | |||
| Price To Earning | 0.70 X | |||
| Price To Book | 1.01 X | |||
| EBITDA | (70.7 M) |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in GRPH Stock
If you are still planning to invest in GRPH Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GRPH Old's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |